Last reviewed · How we verify
alprazolam sublingual tablet
At a glance
| Generic name | alprazolam sublingual tablet |
|---|---|
| Sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence of Alprazolam Sublingual vs Oral Tablets (PHASE1)
- Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation (PHASE1)
- Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation (PHASE1)
- Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet (PHASE1)
- Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: